| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |